MAPK3 and cervical cancer: In further experiments, we treated HeLa cells with LY294002 (an AKT inhibitor) and U0126 (an ERK1/2 inhibitor), and the results showed that both LY294002 and U0126 abolished the promoting effect of SULF2 on the growth of cervical cancer cells.